Exact Mass: 587.3027

Exact Mass Matches: 587.3027

Found 36 metabolites which its exact mass value is equals to given mass value 587.3027, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lipomycin

alpha-Lipomycin

C32H45NO9 (587.3094)

Nummularine R

C33H41N5O5 (587.3108)

Circinadine A

C32H45NO9 (587.3094)

Ludaconitine

[(2R,3R,4R,5S,6S,8R,13R,14R,16S,17S,18R)-11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] benzoate

C32H45NO9 (587.3094)

(1alpha,6alpha,14alpha,16beta)-20-ethyl-1,6,8-trihydroxy-16-methoxy-4-(methoxymethyl)aconitan-14-yl 3,4-dimethoxybenzoate|6-hydroxy-14-O-veratroylneoline|hemsleyaconitine B

C32H45NO9 (587.3094)

Phe Phe Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]hexanoic acid

C33H41N5O5 (587.3108)

Phe Phe Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]hexanamido]-3-phenylpropanoic acid

C33H41N5O5 (587.3108)

Phe Lys Phe Phe

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H41N5O5 (587.3108)

Lys Phe Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H41N5O5 (587.3108)

EGQRV

Glu-Gly-Gln-Arg-Val

C23H41N9O9 (587.3027)

LRGQD

Leu-Arg-Gly-Gln-Asp

C23H41N9O9 (587.3027)

4-[[[5-[[[(2S)-1-[(2-methylpropan-2-yl)oxy]-6-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxohexan-2-yl]amino]-oxomethyl]-1H-imidazol-4-yl]-oxomethyl]amino]benzoic acid ethyl ester

C29H41N5O8 (587.2955)

1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-(2-morpholin-4-ylpyridin-4-yl)urea

C33H41N5O5 (587.3108)

CID 168511217

C23H41N9O9 (587.3027)

ST 20:1;O7;HexNAc

C28H45NO12 (587.2942)

ST 24:5;O4;HexNAc

C32H45NO9 (587.3094)

1-[(13e)-8,11-dihydroxy-16-methoxy-10-(2-methylpropyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

C33H41N5O5 (587.3108)

11-ethyl-8,16,18-trihydroxy-6,12-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3,4-dimethoxybenzoate

C32H45NO9 (587.3094)

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

(2s)-1-[(3s,7s,10s,13z)-8,11-dihydroxy-16-methoxy-10-(sec-butyl)-2-oxa-6,9,12-triazatricyclo[13.3.1.0³,⁷]nonadeca-1(18),8,11,13,15(19),16-hexaen-6-yl]-2-(dimethylamino)-3-(1h-indol-3-yl)propan-1-one

C33H41N5O5 (587.3108)

(1s,2r,3r,4r,5s,6s,8s,9s,10r,13s,16s,17s)-11-ethyl-5,8,17-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.3094)

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

(1-{[(1s)-1-[(1-{[(1s)-1-carboxyethyl]-c-hydroxycarbonimidoyl}-2-hydroxy-3-methylbutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}-2-(4-hydroxyphenyl)ethyl)trimethylazanium

[C30H43N4O8]+ (587.3081)

(1r,2r,3r,4s,5s,6s,8s,9r,10s,13s,14r,16r,17r)-11-ethyl-5,8,14-trihydroxy-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 4-methoxybenzoate

C32H45NO9 (587.3094)

(1s,2r,3r,4s,5r,6s,8r,9r,10r,12s,13r,16s,17s,18r)-11-ethyl-8,16,18-trihydroxy-6,12-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl 3,4-dimethoxybenzoate

C32H45NO9 (587.3094)

(1s,2r,3r,4r,5s,6s,8r,9r,10r,13r,14r,16s,17s,18r)-11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C32H45NO9 (587.3094)

(2r,3r,4r,5s,6s,8r,13r,14r,16s,17s,18r)-11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C32H45NO9 (587.3094)

11-ethyl-5,8,14-trihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate

C32H45NO9 (587.3094)